Recap of the 2025 Annual New York State Hepatitis C and Drug User Health Conference

Recap of the 2025 Annual New York State Hepatitis C and Drug User Health Conference

On September 9th, CEI hosted its first in-person conference dedicated to hepatitis C and drug user health. A group of New York State-based clinicians met in Catskill for a full day agenda focused on (1) integrating wellness into clinical practice as a way to improve patient care and outcomes, and (2) innovative decision-making frameworks to help clinicians navigate complex scenarios in the absence of strong formal evidence, like clinical guidelines and peer reviewed studies.

This episode of “Conversations with CEI” features conference planner and facilitator Taylor Edelmann – an educator and consultant working at the intersection of LGBTQIA+ health, drug user health and harm reduction – sharing his experience and insights about the day. Taylor currently oversees the Lighthouse Learning Collective at the National Harm Reduction Coalition, a program focused on supporting LGBTQIA+ harm reductionists and people who use drugs and engage in sex work. As one of the first openly transgender NCAA athletes, Taylor brings a deeply personal lens to his work advocating for gender-affirming care. He regularly provides clinical education and technical assistance to providers across the country, including Yale University and one of Connecticut’s largest federally qualified health centers, and recently presented at the 2025 Harm Reduction International Conference in Bogotá, Colombia. Taylor is also the co-creator of ChemSex Awareness Week, and the lead author of Gender Affirming Harm Reduction: A Toolkit for Syringe Service Programs, the first resource of its kind developed specifically for social service providers in harm reduction settings. Related Content:

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(74)

Three New Two-Drug Regimens: Which Problem Does Each One Solve?

Three New Two-Drug Regimens: Which Problem Does Each One Solve?

In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, provides an overview of three new two-drug regimens: daily doravirine/islatravi...

22 Okt 18min

Ditching the Script: Person-Centered Contraceptive Counseling

Ditching the Script: Person-Centered Contraceptive Counseling

Erica Bostick, MD is joined by guest speaker Susan Wiener, MD, MPH for this episode of “Conversations with CEI.” Dr. Susan Wiener is an Assistant Professor of Pediatrics in the Division of Adolescent ...

6 Okt 25min

Anabolic Androgenic Steroids: Is “The Cycle” Addictive?

Anabolic Androgenic Steroids: Is “The Cycle” Addictive?

Anabolic androgenic steroids (AAS) are synthetic versions of testosterone, and like naturally produced testosterone, they can increase male sex characteristics and help build muscle. They are prescrib...

24 Sep 21min

AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference

AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference

AIDS 2026, the 26th International AIDS Conference, was held on July 26-31 in Rio. In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellenc...

10 Sep 17min

Updates on HSV Infection

Updates on HSV Infection

Daniela DiMarco, MD, MPH is joined by guest speaker Valeria Cantos, MD for this episode of “Conversations with CEI.” Dr. Valeria Cantos is an Associate Professor at the Division of Infectious Diseases...

27 Aug 22min

Beyond the Script: Applying Harm Reduction Principles in Practice

Beyond the Script: Applying Harm Reduction Principles in Practice

Communication and relationship building are key approaches to harm reduction that focus on meeting people where they are. Both rely on shifting away from stigma and bias to create a safe, open dialogu...

13 Aug 46min

Cardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin

Cardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin

The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline recommends statin therapy for primary prevention of ASCVD for all people living with HIV (PLHIV) aged 40 to 75 years, independently of their tradit...

23 Juli 17min

Best of the Best: Practice-Changing Papers in STI Care from 2025

Best of the Best: Practice-Changing Papers in STI Care from 2025

Hosts Margie Urban, MD, and Daniela DiMarco, MD, MPH, are joined by Jason Zucker, MD. Dr. Zucker is an Assistant Professor of Medicine at the Columbia University Irving Medical Center and is also the ...

9 Juli 21min

Populärt inom Utbildning

husmodern-med-amanda-schulman
rss-bara-en-till-om-beroende-medberoende
historiepodden-se
det-skaver
nu-blir-det-historia
rosceremoni
sektledare
rss-dr-bjorklund
harrisons-dramatiska-historia
not-fanny-anymore
rss-viktmedicinpodden
roda-vita-rosen
allt-du-velat-veta
johannes-hansen-podcast
sa-in-i-sjalen
i-vantan-pa-katastrofen
rss-max-tant-med-max-villman
rss-foraldramotet-bring-lagercrantz
kan-jag-sa-kan-du-podden
rss-traningsklubben